Surmodics delivers third-quarter fiscal 2025 earnings beat with narrower loss, as revenue tops estimates despite lower SurVeil DCB sales.

SurModics (SRDX) delivered earnings and revenue surprises of +128.57% and +4.29%, respectively, for the quarter ended June 2025. Do the numbers hold...

SurModics (SRDX) delivered earnings and revenue surprises of +128.57% and +4.29%, respectively, for the quarter ended June 2025. Do the numbers hold...

Inspire Medical tops second-quarter 2025 earnings estimates and posts solid revenue growth, but trims 2025 guidance amid margin pressure.

Hims & Hers misses second-quarter 2025 EPS and revenue estimates as gross margin narrows, despite strong online sales and subscriber growth.

Doximity beats first-quarter fiscal 2026 estimates with double-digit revenue growth and lifts its full-year forecast.

Doximity beats first-quarter fiscal 2026 estimates with double-digit revenue growth and lifts its full-year forecast.

TSN tops third-quarter fiscal 2025 forecasts as pricing strength and protein demand lift sales and earnings despite soft volumes.

TECH tops Q4 EPS estimates and posts solid revenues, but shrinking margins and operating loss drag shares lower.

AMAT's third-quarter fiscal 2025 earnings reflect higher sales, led by Semiconductor Systems and global revenue gains.